Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Transbound Emerg Dis ; 64(5): 1493-1504, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27390169

ABSTRACT

The eradication of tuberculosis, brucellosis and leucosis in cattle has not yet been achieved in the entire Italian territory. The region of Lazio, Central Italy, represents an interesting case study to evaluate the evolution of costs for these eradication programmes, as in some provinces the eradication has been officially achieved, in some others the prevalence has been close to zero for years, and in still others disease outbreaks have been continuously reported. The objectives of this study were i) to describe the costs for the eradication programmes for tuberculosis, brucellosis and leucosis in cattle carried out in Lazio between 2007 and 2011, ii) to calculate the ratio between the financial contribution of the European Union (EU) for the eradication programmes and the estimated total costs and iii) to estimate the potential savings that can be made when a province gains the certification of freedom from disease. For the i) and ii) objectives, data were collected from official sources and a costing procedure was applied from the perspective of the Regional Health Service. For the iii) objective, a Bayesian AR(1) regression was used to evaluate the average percentage reduction in costs for a province that gained the certification. The total cost for the eradication programmes adjusted for inflation to 1 January 2016 was estimated at 18 919 797 euro (5th and 95th percentiles of the distribution: 18 325 050-19 552 080 euro). When a province gained the certification of freedom from disease, costs decreased on average by (median of the posterior distribution) 47.5%, 54.5% and 54.9% for the eradication programmes of tuberculosis, brucellosis and leucosis, respectively. Information on possible savings from the reduction of control costs can help policy makers operating under budget constraints to justify the use of additional resources for the final phase of eradication.


Subject(s)
Brucellosis, Bovine/prevention & control , Cost Savings/economics , Disease Eradication/economics , Enzootic Bovine Leukosis/prevention & control , Tuberculosis, Bovine/prevention & control , Animals , Bayes Theorem , Brucellosis, Bovine/economics , Cattle , Enzootic Bovine Leukosis/economics , European Union/economics , Italy , Regression Analysis , Tuberculosis, Bovine/economics
2.
Vet Rec ; 179(3): 70-5, 2016 Jul 16.
Article in English | MEDLINE | ID: mdl-27422918

ABSTRACT

Bovine tuberculosis (TB) is a disease of zoonotic importance for which control and eradication programmes have been carried out in many countries for decades. While the impact of these programmes on public health is still uncertain, the impact on trade is significant because of movement restrictions for animals, costs of testing and culling. The objective of this systematic review was to provide a contribution to the general debate over costs against benefits for the control and eradication of bovine TB in cattle. The search strategy was performed on four electronic databases following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The selection process, data abstraction and quality appraisal were carried out according to the Cochrane Collaboration guidelines. The search identified 66 articles out of which eight fulfilled the inclusion criteria. The evidence gathered in this review by combining the conclusions of the most methodologically sound articles supports the idea that, when multiple cost and benefit components are taken into account, efforts to control or eradicate bovine TB may be effective in reducing disease prevalence, economically viable and worth doing.


Subject(s)
Disease Eradication/economics , Tuberculosis, Bovine/economics , Tuberculosis, Bovine/prevention & control , Animals , Cattle , Cost-Benefit Analysis
3.
Obes Rev ; 13(5): 431-40, 2012 May.
Article in English | MEDLINE | ID: mdl-22212590

ABSTRACT

The primary purpose of this study is to analyse the costs related to childhood obesity (CO) with reference to different models of healthcare systems. A systematic review of the economic impact of CO on healthcare systems was conducted by searching the main electronic scientific databases. Cost-of-illness (COI) analyses of children aged under 18 years who had been diagnosed as overweight or obese published up to July 2010 were considered. Short- and long-term consequences of CO were taken into account. In order to appraise the quality of the included studies, the British Medical Journal referees' checklist was used. About 3,844 COI analyses were initially found and 10 were finally considered in the current review: two studies referred to Beveridge and eight referred to Voluntary health insurance models. No studies have been conducted within a Bismarck model. Six studies considered in-patient costs, four studies estimated outpatient and primary care costs and seven studies considered pharmaceutical costs. The average quality of the included analyses was medium. The analysis confirmed the significance of CO related costs and the heterogeneity among available studies, which made it impossible to compare the different healthcare models.


Subject(s)
Cost of Illness , Health Care Costs/statistics & numerical data , Obesity/economics , Child , Humans , Models, Economic , Obesity/psychology , Severity of Illness Index
4.
Ann Ig ; 21(2): 117-26, 2009.
Article in Italian | MEDLINE | ID: mdl-19653443

ABSTRACT

The objective of our research is to report on the diffusion of Clinical Governance, as introduced with the National Health Plan 2006-2008, by analysing the planning instruments set up by each Region (Regional Health Plans and Emergency Plans in regions with budget deficit), the organizational frameworks (Atti Aziendali, firm acts), and the surveys on performance and quality of healthcare among the Italian Local Health Units (Health Surveys). Our research was realized on September-December 2007 and consisted of the collection of all retrieved documents available on the web and on the online public access catalog (OPAC SBN) of the National Library Service. Futhermore, each document has been classified and analysed according to Chambers' Clinical Governance definition. A descriptive statistical and inferential analysis by applying the Chi-2 Test was performed to test the correlation between the diffusion of such a classified documents and the geographical partition of each LHU. Our results show a scarce diffusion of Firm acts (43%) and Health Surveys (24.9% of the total). Any remind to Clinical Governance instruments and methods inside each document resulted even poorer among both the organizational and performance surveys and the regional health planning frameworks, respectively.


Subject(s)
Clinical Governance/legislation & jurisprudence , Community Health Centers/legislation & jurisprudence , Health Planning , Community Health Centers/organization & administration , Cross-Sectional Studies , Health Care Surveys , Health Services Accessibility , Humans , Italy , Quality of Health Care , Sicily
5.
Diabetes Res Clin Pract ; 85(2): 119-31, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19539391

ABSTRACT

BACKGROUND: Our aim is to review the effectiveness of EBM tools available to primary care professionals to improve the quality of Type 2 diabetes disease management. METHODS: A systematic review of RCT was performed according to the Cochrane methods. RESULTS: Starting from an overall number of 1737 references found, a total of 13 studies met all the inclusion criteria. CONCLUSIONS: The adherence to EBM instruments is likely to improve process of care, rather than patient outcomes. In addition, our review outlines that feedback reports and use of ICT devices are likely to be effective in diabetes disease management.


Subject(s)
Diabetes Mellitus, Type 2/therapy , Evidence-Based Medicine/standards , Physicians/standards , Humans , Patient Education as Topic , Physician-Patient Relations , Practice Guidelines as Topic , Primary Health Care/standards , Randomized Controlled Trials as Topic , Reproducibility of Results , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...